Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Codeine phosphate (anhydrous) 8 mg, paracetamol 4% PVP 520.8 mg equivalent to 500 mg paracetamol Tablet Anzapharm Limited, Glenfield, Auckland Codimyl Indinavir sulphate 416.3 mg equivalent to 333 mg indinavir Capsule Merck & Co Inc., Elkton, Virginia, United States of America Crixivan Alcohol 22.57 w/v, benzoic acid 0.12% w/v, cineole 0.0922% w/v, thymol 0.0639% w/v Mouthwash, solution Parke Davis Pty Limited, Caringbah, Sydney, New South Wales, Australia Listerine Freshburst Antiseptic Mouthwash Isotretinoin 20 mg Note: Not to be marketed as substitutable for any other isotretinoin product as if the two products were bioequivalent. Capsule, soft gelatin SCA-Lohnherstellungs AG., Kirchberg, Switzerland Oratane Cajaput oil 7% w/w, camphor 11% w/w, clove oil 5% w/w, menthol 10% w/w Ointment, topical Drug Houses of Australia (Asia) Pte Limited, Singapore Tiger Balm Red Cajaput oil 13% w/w, camphor 11% w/w, clove oil 1.5% w/w, menthol 8% w/w Ointment, topical Drug Houses of Australia (Asia) Pte Limited, Singapore Tiger Balm White Dated this 13th day of May 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.